Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Molecular Genetics Laboratory, |
RCV001174036 | SCV001337156 | uncertain significance | Charcot-Marie-Tooth disease | criteria provided, single submitter | clinical testing | ||
Ambry Genetics | RCV002327423 | SCV002630742 | uncertain significance | Inborn genetic diseases | 2021-09-22 | criteria provided, single submitter | clinical testing | The p.D390Y variant (also known as c.1168G>T), located in coding exon 10 of the SH3TC2 gene, results from a G to T substitution at nucleotide position 1168. The aspartic acid at codon 390 is replaced by tyrosine, an amino acid with highly dissimilar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Athena Diagnostics | RCV002473212 | SCV002771246 | uncertain significance | not provided | 2022-05-04 | criteria provided, single submitter | clinical testing |